Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Bonella

Showing results (11-20 of 191) with videos related to

Pageof 20
Sort By:
Therapeutics and Clinical Risk Management|March 14, 2015
Update on therapeutic management of idiopathic pulmonary fibrosisArgyris Tzouvelekis, Francesco Bonella, Paolo Spagnolo
Current Opinion in Pulmonary Medicine|August 1, 2019
Shaping the future of an ultra-rare disease: unmet needs in the diagnosis and treatment of pulmonary alveolar proteinosisCormac McCarthy, Maria Kokosi, Francesco Bonella
Drug Design, Development and Therapy|December 31, 2015
Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanibFrancesco Bonella, Susanne Stowasser, Lutz Wollin
Clinics in Chest Medicine|February 28, 2012
Chronic hypersensitivity pneumonitisUlrich Costabel, Francesco Bonella, Josune Guzman
Respiratory Medicine|September 27, 2017
Therapeutic targets in idiopathic pulmonary fibrosisMartin Kolb, Francesco Bonella, Lutz Wollin
European Respiratory Review : an Official Journal of the European Respiratory Society|March 19, 2025
The role of heat shock protein 90 in idiopathic pulmonary fibrosis: state of the artGiorgio Monteleone, Paolo Cameli, Francesco Bonella
Seminars in Respiratory and Critical Care Medicine|October 14, 2025
Pulmonary AmyloidosisStefano Levra, Marcel Opitz, Francesco Bonella
Pneumologie (Stuttgart, Germany)|October 16, 2025
[Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis]Francesco Bonella, Katja Schillhorn, Marjolein Drent
Expert Review of Respiratory Medicine|July 7, 2015
Facts and promises on lung biomarkers in interstitial lung diseasesIlaria Campo, Michele Zorzetto, Francesco Bonella
Frontiers in Medicine|July 18, 2018
The Management of Patients With Idiopathic Pulmonary FibrosisPaolo Spagnolo, Argyris Tzouvelekis, Francesco Bonella
Pageof 20

Showing results (11-20 of 191) with videos related to

Sort By:
Pageof 20
Therapeutics and Clinical Risk Management|March 14, 2015
Update on therapeutic management of idiopathic pulmonary fibrosisArgyris Tzouvelekis, Francesco Bonella, Paolo Spagnolo
Current Opinion in Pulmonary Medicine|August 1, 2019
Shaping the future of an ultra-rare disease: unmet needs in the diagnosis and treatment of pulmonary alveolar proteinosisCormac McCarthy, Maria Kokosi, Francesco Bonella
Drug Design, Development and Therapy|December 31, 2015
Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanibFrancesco Bonella, Susanne Stowasser, Lutz Wollin
Clinics in Chest Medicine|February 28, 2012
Chronic hypersensitivity pneumonitisUlrich Costabel, Francesco Bonella, Josune Guzman
Respiratory Medicine|September 27, 2017
Therapeutic targets in idiopathic pulmonary fibrosisMartin Kolb, Francesco Bonella, Lutz Wollin
European Respiratory Review : an Official Journal of the European Respiratory Society|March 19, 2025
The role of heat shock protein 90 in idiopathic pulmonary fibrosis: state of the artGiorgio Monteleone, Paolo Cameli, Francesco Bonella
Seminars in Respiratory and Critical Care Medicine|October 14, 2025
Pulmonary AmyloidosisStefano Levra, Marcel Opitz, Francesco Bonella
Pneumologie (Stuttgart, Germany)|October 16, 2025
[Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis]Francesco Bonella, Katja Schillhorn, Marjolein Drent
Expert Review of Respiratory Medicine|July 7, 2015
Facts and promises on lung biomarkers in interstitial lung diseasesIlaria Campo, Michele Zorzetto, Francesco Bonella
Frontiers in Medicine|July 18, 2018
The Management of Patients With Idiopathic Pulmonary FibrosisPaolo Spagnolo, Argyris Tzouvelekis, Francesco Bonella
Pageof 20